SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): July 2, 2007
TECH
LABORATORIES, INC.
(Exact
name of registrant as specified in its charter)
New
Jersey
|
000-27592
|
22-1436279
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
1818
North Farwell Avenue, Milwaukee, Wisconsin 53202
(Address
of principal executive offices) (Zip Code)
Copies
to:
Thomas
A.
Rose, Esq.
Yoel
Goldfeder, Esq.
Sichenzia
Ross Friedman Ference LLP
1065
Avenue of the Americas
New
York,
New York 10018
Phone:
(212) 930-9700
Fax:
(212) 930-9725
N/A
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item
1.01 Entry into a Material Definitive Agreement.
Acquisition
of BSI
On
July
2, 2007, Tech Laboratories, Inc. (the “Company”), and BSI Acquisitions, Inc.
(“Acquisitions”), its wholly-owned subsidiary, entered into a merger agreement
(the “Merger Agreement”) with Biodeisel Solutions, Inc. (“BSI”). Pursuant to the
Merger Agreement, Acquisitions was merged with and into BSI. The former
shareholders of BSI were issued an aggregate of 49,000,000 of Common Stock
of
the Company (the "Common Stock"), 1,000,000 shares of BSI series B convertible
stock (the “Preferred Stock”) and $500,000 in cash. The shares of Preferred
Stock issued to the former BSI shareholders are immediately convertible at
the
option of the holders into Common Stock at a conversion price per share equal
to
the greater of (i) $0.05, or (ii) the average closing price of the Common Stock
during the ten trading days immediately preceding the conversion date.
BSI
manufactures the BiodieselMaster®, a factory-built biodiesel processing plant
that is appropriately scaled for a variety of customers, including small
communities, farms, farm co-ops and trucking fleets. The BiodieselMaster is
a
community-scale biodiesel processing unit that is designed to produce 350,000
gallons of biodiesel per year. The design provides a biodiesel production system
that is continuous, flexible, efficient, affordable, and fully-automated. The
automated control system minimizes labor costs and facilitates remote
diagnostics.
Financing
With Cornell Capital Partners, L.P.
On
July
2, 2007, the Company entered into a Securities Purchase Agreement (the "Purchase
Agreement") with Cornell Capital Partners L.P. ("Cornell") providing for the
sale by the Company to Cornell of its secured convertible debentures in the
aggregate principal amount of $2,700,000 (the "Debentures") of which $2,000,000
was advanced immediately. The second installment of $700,000 will be funded
within two business days after the Company shall have unconditionally booked
and
received at least a 50% deposit for the sale of at least one BioDieselMaster
Unit.
The
Debentures bear interest at the prime rate plus 2.75% (but not less than 10%)
and mature two years from the date of issuance (the "Maturity Date"). The
Company is not required to make any payments until the Maturity Date. The holder
of the Debentures may convert at any time amounts outstanding into shares of
Common Stock at a conversion price per share equal to the lesser of (i) $0.05,
or (ii) 80% of the lowest closing bid price of the Common Stock during the
ten
trading days immediately preceding the conversion date.
The
Company has the right to redeem a portion or all amounts outstanding under
the
Debenture prior to the Maturity Date at a 15% redemption premium provided that
(i) the average volume weighted average price of the Company’s Common Stock is
less than the conversion price of the Debentures; (ii) the underlying shares
are
subject to an effective registration statement; and (iii) no event of default
has occurred.
The
obligations to Cornell, together with prior obligations to Cornell, are secured
by a security interest in the Company’s assets and the assets of its
subsidiaries, including their intellectual property. In addition, the Company
pledged the shares of BSI to Cornell as additional security for the obligations
to Cornell.
Under
the
Purchase Agreement, the Company also issued to Cornell five-year warrants to
purchase 33,750,000 shares of common stock at $0.06 per share.
In
connection with the Purchase Agreement, the Company also amended its
registration rights agreement with Cornell (the "Registration Rights Agreement")
providing for the filing of a registration statement (the "Registration
Statement") with the SEC registering the common stock issuable upon conversion
of the Debentures and exercise of the warrants. Upon written demand from the
Holder, the Company is obligated to file a Registration Statement within 45
days
of such demand. The Company is obligated to use its best efforts to cause the
Registration Statement to be declared effective no later than 150 days following
receipt of a written demand for the filing of a Registration Statement and
to
insure that the Registration Statement remains in effect until all of the shares
of common stock issuable upon conversion of the Debentures and exercise of
the
warrants have been sold or may be sold without volume restrictions pursuant
to
Rule 144(k) promulgated by the SEC. In the event of a default of its obligations
under the Registration Rights Agreement, including its agreement with respect
to
the filing and effectiveness dates for the Registration Statement, the Company
is required to pay to Cornell, as liquidated damages, for each thirty day period
that the registration statement has not been filed or declared effective, as
the
case may be, a cash amount equal to 2% of the liquidated value of the
Debentures, not to exceed 24%.
Item
2.03 Creation of a Direct Financial Obligation
See
Item
1.01.
Item
3.02 Unregistered Sales of Equity Securities
See
Item
1.01
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
Exhibit
Number
|
|
Description
|
10.1
|
|
Agreement
and Plan of Merger, dated July 2, 2007, among Tech Laboratories,
Inc., BSI
Acquisitions, Inc. and Biodeisel Solutions, Inc.
|
|
|
|
10.2
|
|
Securities
Purchase Agreement, dated July 2, 2007, by and between Tech Laboratories,
Inc. and Cornell Capital Partners L.P.
|
|
|
|
10.3
|
|
$2,000,000
principal amount Secured Convertible Debenture, dated July 2, 2007,
by and
between Tech Laboratories, Inc. and Cornell Capital Partners L.P.
|
|
|
|
10.4
|
|
Warrant
to purchase 33,750,000 shares of Common Stock of Tech Laboratories,
Inc.
dated April 20, 2007
|
|
|
|
10.5
|
|
Registration
Rights Agreement, dated April 20, 2007, by and between Tech Laboratories,
Inc. and Cornell Capital Partners L.P. (incorporated by reference
to the
exhibits to Registrants Form 8-K filed on April 26,
2007).
|
|
|
|
10.6
|
|
Amendment
No. 1 to Registration Rights Agreement, dated July 2, 2007, by and
between
Tech Laboratories, Inc. and Cornell Capital Partners L.P.
|
|
|
|
10.7
|
|
Security
Agreement, dated July 2, 2007, by and between Biodeisel Solutions,
Inc.,
Renewal Fuels, Inc. and Cornell Capital Partners L.P.
|
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
TECH LABORATORIES, INC. |
|
|
|
Dated: July 6, 2007 |
By: |
/s/ John King |
|
Name:
John King |
|
Title:
Chief Executive Officer
|